Ikena Oncology Inc (NASDAQ: IKNA) on Monday, soared 7.74% from the previous trading day, before settling in for the closing price of $1.55. Within the past 52 weeks, IKNA’s price has moved between $1.22 and $2.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 280.42% annually for the last half of the decade. The company achieved an average annual earnings per share of 28.07%. With a float of $27.31 million, this company’s outstanding shares have now reached $48.26 million.
In an organization with 43 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 6.53%, operating margin of -9878.45%, and the pretax margin is -9053.41%.
Ikena Oncology Inc (IKNA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ikena Oncology Inc is 43.40%, while institutional ownership is 25.98%.
Ikena Oncology Inc (IKNA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.07% per share during the next fiscal year.
Ikena Oncology Inc (NASDAQ: IKNA) Trading Performance Indicators
Ikena Oncology Inc (IKNA) is currently performing well based on its current performance indicators. A quick ratio of 15.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 122.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.03 in one year’s time.
Technical Analysis of Ikena Oncology Inc (IKNA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.17 million. That was better than the volume of 0.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 32.96%. Additionally, its Average True Range was 0.09.
During the past 100 days, Ikena Oncology Inc’s (IKNA) raw stochastic average was set at 35.71%, which indicates a significant increase from 35.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.68% in the past 14 days, which was higher than the 29.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6931, while its 200-day Moving Average is $1.6046. However, in the short run, Ikena Oncology Inc’s stock first resistance to watch stands at $1.8633. Second resistance stands at $2.0567. The third major resistance level sits at $2.1733. If the price goes on to break the first support level at $1.5533, it is likely to go to the next support level at $1.4367. The third support level lies at $1.2433 if the price breaches the second support level.
Ikena Oncology Inc (NASDAQ: IKNA) Key Stats
Market capitalization of the company is 80.59 million based on 48,258K outstanding shares. Right now, sales total 9,160 K and income totals -68,170 K. The company made 0 K in profit during its latest quarter, and -10,230 K in sales during its previous quarter.
